Chapter 15. Targeting the estrogen receptor with SERMs

被引:13
作者
Miller, CP [1 ]
Komm, BS [1 ]
机构
[1] Wyeth Ayerst Res, Radnor, PA 19087 USA
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36 | 2001年 / 36卷
关键词
D O I
10.1016/S0065-7743(01)36055-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:149 / 158
页数:10
相关论文
共 74 条
[1]  
AGNUSDEI D, 2000, NEURON INTERACT, V1, P127
[2]   The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats [J].
Ammann, P ;
Bourrin, S ;
Bonjour, JP ;
Brunner, F ;
Meyer, JM ;
Rizzoli, R .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (05) :369-376
[3]  
BELL MG, 2000, 219 AM CHEM SOC NATL
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF TAMOXIFEN, TOREMIFENE AND THEIR MAJOR HUMAN METABOLITES [J].
BERTHOU, F ;
DREANO, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 616 (01) :117-127
[5]   2-phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity [J].
Biberger, C ;
vonAngerer, E .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 58 (01) :31-43
[6]  
BITONTI AJ, 1996, Patent No. 9616646
[7]  
BOUALI Y, 1998, Patent No. 2757519
[8]  
BOUALI Y, 1998, Patent No. 2757399
[9]   ESTRADIOL DERIVATIVES BEARING THE SIDE-CHAIN OF TAMOXIFEN ANTAGONIZE THE ASSOCIATION BETWEEN THE ESTROGEN-RECEPTOR AND CALMODULIN [J].
BOUHOUTE, A ;
LECLERCQ, G .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (04) :748-751
[10]  
Bryant HU, 1998, P SOC EXP BIOL MED, V217, P45